D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats
Long-term occupancy of dopamine D 2 -receptors, as achieved by chronic treatment with antipsychotics, leads to D 2 -receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D...
Gespeichert in:
Veröffentlicht in: | Neuropsychopharmacology (New York, N.Y.) N.Y.), 2009-02, Vol.34 (3), p.662-671 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 671 |
---|---|
container_issue | 3 |
container_start_page | 662 |
container_title | Neuropsychopharmacology (New York, N.Y.) |
container_volume | 34 |
creator | Ginovart, Nathalie Wilson, Alan A Hussey, Doug Houle, Sylvain Kapur, Shitij |
description | Long-term occupancy of dopamine D
2
-receptors, as achieved by chronic treatment with antipsychotics, leads to D
2
-receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D
2
-receptor blockade (duration and percentage of blockade) that lead to upregulation. In this study, we investigated the effects of different degrees (60
vs
>80%) and durations (a transient peak
vs
24 h/day) of D
2
-receptor blockade on inducing this upregulation. These different patterns of D
2
-receptor occupancy kinetics were produced in cats using bolus
vs
constant infusion of haloperidol for 4 weeks. D
2
-receptors were measured using positron emission tomography and Scatchard analyses of [
11
C]raclopride binding, before and after withdrawal of treatment. Continuously high (80% for 24 h/day) D
2
-receptor blockade led to a robust upregulation of striatal D
2
-receptors that was maximal at 1-week withdrawal (35±5%) and still detectable at 2-week withdrawal (20±3%). This pattern of D
2
-receptor blockade also induced behavioral tolerance to the effect of haloperidol on spontaneous locomotor activity. Continuously moderate (60% for 24 h/day) or transiently high (80% for a few hours/day) D
2
-receptor blockade did not produce any of these effects. The long-term effect of haloperidol on D
2
-receptor density and behavioral tolerance thus appears to be dependent not only on a critical threshold of D
2
-receptor blockade but also on the daily duration of D
2
-receptors blockade. This suggests that as far as antipsychotics are concerned, not only dose but disbursment throughout the day have an impact on eventual pharmacodynamic and behavioral outcomes. |
doi_str_mv | 10.1038/npp.2008.116 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66807771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1625226691</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1196-ccd23c2fbe898c48959e08f772ada615a74e5f8c0218da7adeecf0a560ac17583</originalsourceid><addsrcrecordid>eNpdkcFLHDEUxoO06Hb11nMJPfQ2a16yk2R6k9GqsLBFVxCkhJh5s4zMJnEyc9iD_3sjWgqeHrz3ex9830fIV2ALYEKf-hgXnDG9AJAHZAZqyQoplvefyIzpShQgxP0R-ZLSE2NQKqkPyRFoqTUHNiMv57y4QYdxDAO9iwNup96OXfC0S_QcI_oG_UinmDcb3MUw2J7WYRoS0tDS_L12borWu_1PekZXwW-7cWo6n7EHgPpPcWNdH-LQNUh_X2zobb7uaedpbcd0TD63tk948j7n5O7Xxaa-Klbry-v6bFVEgEoWzjVcON4-oq60W-qqrJDpViluGyuhtGqJZasd46Abq2yD6FpmS8msA1VqMSc_3nTjEJ4nTKPZdclh31uPYUpGSs2UUpDB7x_Ap-w1m0mG85IzkdPN0Ld3aHrcYWOyuZ0d9uZfqhko3oCUT36Lw38VYOa1NZNbM6-tmdya-Avuk4eh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>225203740</pqid></control><display><type>article</type><title>D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ginovart, Nathalie ; Wilson, Alan A ; Hussey, Doug ; Houle, Sylvain ; Kapur, Shitij</creator><creatorcontrib>Ginovart, Nathalie ; Wilson, Alan A ; Hussey, Doug ; Houle, Sylvain ; Kapur, Shitij</creatorcontrib><description>Long-term occupancy of dopamine D
2
-receptors, as achieved by chronic treatment with antipsychotics, leads to D
2
-receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D
2
-receptor blockade (duration and percentage of blockade) that lead to upregulation. In this study, we investigated the effects of different degrees (60
vs
>80%) and durations (a transient peak
vs
24 h/day) of D
2
-receptor blockade on inducing this upregulation. These different patterns of D
2
-receptor occupancy kinetics were produced in cats using bolus
vs
constant infusion of haloperidol for 4 weeks. D
2
-receptors were measured using positron emission tomography and Scatchard analyses of [
11
C]raclopride binding, before and after withdrawal of treatment. Continuously high (80% for 24 h/day) D
2
-receptor blockade led to a robust upregulation of striatal D
2
-receptors that was maximal at 1-week withdrawal (35±5%) and still detectable at 2-week withdrawal (20±3%). This pattern of D
2
-receptor blockade also induced behavioral tolerance to the effect of haloperidol on spontaneous locomotor activity. Continuously moderate (60% for 24 h/day) or transiently high (80% for a few hours/day) D
2
-receptor blockade did not produce any of these effects. The long-term effect of haloperidol on D
2
-receptor density and behavioral tolerance thus appears to be dependent not only on a critical threshold of D
2
-receptor blockade but also on the daily duration of D
2
-receptors blockade. This suggests that as far as antipsychotics are concerned, not only dose but disbursment throughout the day have an impact on eventual pharmacodynamic and behavioral outcomes.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/npp.2008.116</identifier><identifier>PMID: 18688210</identifier><identifier>CODEN: NEROEW</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Animals ; Antipsychotics ; Behavioral Sciences ; Biological Psychology ; Cats ; Corpus Striatum - diagnostic imaging ; Corpus Striatum - drug effects ; Dopamine ; Dopamine D2 Receptor Antagonists ; Dose-Response Relationship, Drug ; Drug dosages ; Drug Tolerance ; Drug withdrawal ; Dyskinesia ; Haloperidol - administration & dosage ; Haloperidol - pharmacology ; Longitudinal Studies ; Medicine ; Medicine & Public Health ; Motor Activity - drug effects ; Neurosciences ; original-article ; Pharmacotherapy ; Positron-Emission Tomography ; Psychiatry ; Psychotropic drugs ; Raclopride - metabolism ; Receptors, Dopamine D2 - metabolism ; Tomography ; Up-Regulation - drug effects</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2009-02, Vol.34 (3), p.662-671</ispartof><rights>American College of Neuropsychopharmacology 2009</rights><rights>Copyright Nature Publishing Group Feb 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/npp.2008.116$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/npp.2008.116$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18688210$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ginovart, Nathalie</creatorcontrib><creatorcontrib>Wilson, Alan A</creatorcontrib><creatorcontrib>Hussey, Doug</creatorcontrib><creatorcontrib>Houle, Sylvain</creatorcontrib><creatorcontrib>Kapur, Shitij</creatorcontrib><title>D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacol</addtitle><addtitle>Neuropsychopharmacology</addtitle><description>Long-term occupancy of dopamine D
2
-receptors, as achieved by chronic treatment with antipsychotics, leads to D
2
-receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D
2
-receptor blockade (duration and percentage of blockade) that lead to upregulation. In this study, we investigated the effects of different degrees (60
vs
>80%) and durations (a transient peak
vs
24 h/day) of D
2
-receptor blockade on inducing this upregulation. These different patterns of D
2
-receptor occupancy kinetics were produced in cats using bolus
vs
constant infusion of haloperidol for 4 weeks. D
2
-receptors were measured using positron emission tomography and Scatchard analyses of [
11
C]raclopride binding, before and after withdrawal of treatment. Continuously high (80% for 24 h/day) D
2
-receptor blockade led to a robust upregulation of striatal D
2
-receptors that was maximal at 1-week withdrawal (35±5%) and still detectable at 2-week withdrawal (20±3%). This pattern of D
2
-receptor blockade also induced behavioral tolerance to the effect of haloperidol on spontaneous locomotor activity. Continuously moderate (60% for 24 h/day) or transiently high (80% for a few hours/day) D
2
-receptor blockade did not produce any of these effects. The long-term effect of haloperidol on D
2
-receptor density and behavioral tolerance thus appears to be dependent not only on a critical threshold of D
2
-receptor blockade but also on the daily duration of D
2
-receptors blockade. This suggests that as far as antipsychotics are concerned, not only dose but disbursment throughout the day have an impact on eventual pharmacodynamic and behavioral outcomes.</description><subject>Animals</subject><subject>Antipsychotics</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Cats</subject><subject>Corpus Striatum - diagnostic imaging</subject><subject>Corpus Striatum - drug effects</subject><subject>Dopamine</subject><subject>Dopamine D2 Receptor Antagonists</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug dosages</subject><subject>Drug Tolerance</subject><subject>Drug withdrawal</subject><subject>Dyskinesia</subject><subject>Haloperidol - administration & dosage</subject><subject>Haloperidol - pharmacology</subject><subject>Longitudinal Studies</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Motor Activity - drug effects</subject><subject>Neurosciences</subject><subject>original-article</subject><subject>Pharmacotherapy</subject><subject>Positron-Emission Tomography</subject><subject>Psychiatry</subject><subject>Psychotropic drugs</subject><subject>Raclopride - metabolism</subject><subject>Receptors, Dopamine D2 - metabolism</subject><subject>Tomography</subject><subject>Up-Regulation - drug effects</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkcFLHDEUxoO06Hb11nMJPfQ2a16yk2R6k9GqsLBFVxCkhJh5s4zMJnEyc9iD_3sjWgqeHrz3ex9830fIV2ALYEKf-hgXnDG9AJAHZAZqyQoplvefyIzpShQgxP0R-ZLSE2NQKqkPyRFoqTUHNiMv57y4QYdxDAO9iwNup96OXfC0S_QcI_oG_UinmDcb3MUw2J7WYRoS0tDS_L12borWu_1PekZXwW-7cWo6n7EHgPpPcWNdH-LQNUh_X2zobb7uaedpbcd0TD63tk948j7n5O7Xxaa-Klbry-v6bFVEgEoWzjVcON4-oq60W-qqrJDpViluGyuhtGqJZasd46Abq2yD6FpmS8msA1VqMSc_3nTjEJ4nTKPZdclh31uPYUpGSs2UUpDB7x_Ap-w1m0mG85IzkdPN0Ld3aHrcYWOyuZ0d9uZfqhko3oCUT36Lw38VYOa1NZNbM6-tmdya-Avuk4eh</recordid><startdate>200902</startdate><enddate>200902</enddate><creator>Ginovart, Nathalie</creator><creator>Wilson, Alan A</creator><creator>Hussey, Doug</creator><creator>Houle, Sylvain</creator><creator>Kapur, Shitij</creator><general>Springer International Publishing</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>200902</creationdate><title>D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats</title><author>Ginovart, Nathalie ; Wilson, Alan A ; Hussey, Doug ; Houle, Sylvain ; Kapur, Shitij</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1196-ccd23c2fbe898c48959e08f772ada615a74e5f8c0218da7adeecf0a560ac17583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antipsychotics</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Cats</topic><topic>Corpus Striatum - diagnostic imaging</topic><topic>Corpus Striatum - drug effects</topic><topic>Dopamine</topic><topic>Dopamine D2 Receptor Antagonists</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug dosages</topic><topic>Drug Tolerance</topic><topic>Drug withdrawal</topic><topic>Dyskinesia</topic><topic>Haloperidol - administration & dosage</topic><topic>Haloperidol - pharmacology</topic><topic>Longitudinal Studies</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Motor Activity - drug effects</topic><topic>Neurosciences</topic><topic>original-article</topic><topic>Pharmacotherapy</topic><topic>Positron-Emission Tomography</topic><topic>Psychiatry</topic><topic>Psychotropic drugs</topic><topic>Raclopride - metabolism</topic><topic>Receptors, Dopamine D2 - metabolism</topic><topic>Tomography</topic><topic>Up-Regulation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ginovart, Nathalie</creatorcontrib><creatorcontrib>Wilson, Alan A</creatorcontrib><creatorcontrib>Hussey, Doug</creatorcontrib><creatorcontrib>Houle, Sylvain</creatorcontrib><creatorcontrib>Kapur, Shitij</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ginovart, Nathalie</au><au>Wilson, Alan A</au><au>Hussey, Doug</au><au>Houle, Sylvain</au><au>Kapur, Shitij</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><stitle>Neuropsychopharmacol</stitle><addtitle>Neuropsychopharmacology</addtitle><date>2009-02</date><risdate>2009</risdate><volume>34</volume><issue>3</issue><spage>662</spage><epage>671</epage><pages>662-671</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><coden>NEROEW</coden><abstract>Long-term occupancy of dopamine D
2
-receptors, as achieved by chronic treatment with antipsychotics, leads to D
2
-receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D
2
-receptor blockade (duration and percentage of blockade) that lead to upregulation. In this study, we investigated the effects of different degrees (60
vs
>80%) and durations (a transient peak
vs
24 h/day) of D
2
-receptor blockade on inducing this upregulation. These different patterns of D
2
-receptor occupancy kinetics were produced in cats using bolus
vs
constant infusion of haloperidol for 4 weeks. D
2
-receptors were measured using positron emission tomography and Scatchard analyses of [
11
C]raclopride binding, before and after withdrawal of treatment. Continuously high (80% for 24 h/day) D
2
-receptor blockade led to a robust upregulation of striatal D
2
-receptors that was maximal at 1-week withdrawal (35±5%) and still detectable at 2-week withdrawal (20±3%). This pattern of D
2
-receptor blockade also induced behavioral tolerance to the effect of haloperidol on spontaneous locomotor activity. Continuously moderate (60% for 24 h/day) or transiently high (80% for a few hours/day) D
2
-receptor blockade did not produce any of these effects. The long-term effect of haloperidol on D
2
-receptor density and behavioral tolerance thus appears to be dependent not only on a critical threshold of D
2
-receptor blockade but also on the daily duration of D
2
-receptors blockade. This suggests that as far as antipsychotics are concerned, not only dose but disbursment throughout the day have an impact on eventual pharmacodynamic and behavioral outcomes.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>18688210</pmid><doi>10.1038/npp.2008.116</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-133X |
ispartof | Neuropsychopharmacology (New York, N.Y.), 2009-02, Vol.34 (3), p.662-671 |
issn | 0893-133X 1740-634X |
language | eng |
recordid | cdi_proquest_miscellaneous_66807771 |
source | MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Animals Antipsychotics Behavioral Sciences Biological Psychology Cats Corpus Striatum - diagnostic imaging Corpus Striatum - drug effects Dopamine Dopamine D2 Receptor Antagonists Dose-Response Relationship, Drug Drug dosages Drug Tolerance Drug withdrawal Dyskinesia Haloperidol - administration & dosage Haloperidol - pharmacology Longitudinal Studies Medicine Medicine & Public Health Motor Activity - drug effects Neurosciences original-article Pharmacotherapy Positron-Emission Tomography Psychiatry Psychotropic drugs Raclopride - metabolism Receptors, Dopamine D2 - metabolism Tomography Up-Regulation - drug effects |
title | D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A22%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=D2-Receptor%20Upregulation%20is%20Dependent%20upon%20Temporal%20Course%20of%20D2-Occupancy:%20A%20Longitudinal%20%5B11C%5D-Raclopride%20PET%20Study%20in%20Cats&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=Ginovart,%20Nathalie&rft.date=2009-02&rft.volume=34&rft.issue=3&rft.spage=662&rft.epage=671&rft.pages=662-671&rft.issn=0893-133X&rft.eissn=1740-634X&rft.coden=NEROEW&rft_id=info:doi/10.1038/npp.2008.116&rft_dat=%3Cproquest_pubme%3E1625226691%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=225203740&rft_id=info:pmid/18688210&rfr_iscdi=true |